Emily K Bergsland Selected Research

Emily K Bergsland Research Topics

Disease

22	Neoplasms (Cancer) 11/2021 - 04/2003
17	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 08/2006
8	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2005
8	Carcinoid Tumor (Carcinoid) 01/2019 - 08/2006
7	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 11/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010 - 01/2006
4	Carcinoma (Carcinomatosis) 12/2016 - 10/2012
4	Adenocarcinoma 11/2010 - 01/2006
2	Circulating Neoplastic Cells 01/2017 - 10/2008
2	Liver Diseases (Liver Disease) 12/2016 - 06/2014
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2016 - 06/2014
1	Hyperparathyroidism 01/2021
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 12/2018
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2017
1	Neuroendocrine Carcinoma 11/2016
1	Cholangiocarcinoma 06/2014
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2012
1	Hand-Foot Syndrome 10/2012
1	Rectal Neoplasms (Rectal Cancer) 07/2011
1	Cushing Syndrome 09/2010
1	Heart Valve Diseases (Valvular Heart Disease) 03/2010
1	Flushing 03/2010
1	Diarrhea 03/2010
1	Respiratory Sounds (Crackle) 03/2010
1	Lymphatic Metastasis 03/2010
1	Insulinoma 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2008

Drug/Important Bio-Agent (IBA)

7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 11/2004
7	Gemcitabine FDA Link 10/2012 - 01/2006
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019 - 06/2007
4	Everolimus FDA Link 12/2018 - 01/2009
4	Bevacizumab (Avastin)FDA Link 11/2016 - 11/2004
3	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 06/2012
3	Radioisotopes (Radionuclides)IBA 01/2022 - 06/2012
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2019 - 06/2012
3	TOR Serine-Threonine KinasesIBA 05/2015 - 06/2012
3	Hormones (Hormone)IBA 06/2012 - 03/2010
3	Cisplatin (Platino)FDA LinkGeneric 10/2008 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2005
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2008
2	PlatinumIBA 02/2013 - 01/2006
2	Capecitabine (Xeloda)FDA Link 10/2012 - 07/2007
2	Serotonin (5 Hydroxytryptamine)IBA 09/2010 - 03/2010
2	Monoclonal AntibodiesIBA 10/2008 - 11/2004
2	Dihydrotachysterol (AT 10)IBA 07/2007 - 01/2006
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 01/2021
1	fluorocholineIBA 01/2021
1	Ga(III)-DOTATOCIBA 01/2021
1	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2021
1	hydroxide ionIBA 12/2019
1	25-hydroxyvitamin DIBA 12/2019
1	Vitamin D FDA LinkGeneric 12/2019
1	Fibronectins (Fibronectin)IBA 03/2019
1	MitogensIBA 03/2019
1	LumicanIBA 03/2019
1	Metalloproteases (Metalloproteinases)IBA 03/2019
1	Thymidylate SynthaseIBA 01/2019
1	GalliumIBA 01/2019
1	Edotreotide (SMT 487)IBA 01/2019
1	Investigational DrugsIBA 12/2018
1	sapanisertibIBA 12/2018
1	Gallium-68IBA 12/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	telotristat ethylIBA 01/2017
1	tumor-associated antigen 72IBA 01/2017
1	lanreotide (Somatuline)FDA Link 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2015
1	Diphosphonates (Bisphosphonates)IBA 03/2015
1	Denosumab FDA Link 03/2015
1	Epidermal Growth Factor (EGF)IBA 02/2015
1	figitumumabIBA 04/2014
1	Adenosine Triphosphate (ATP)IBA 12/2012
1	PP242IBA 12/2012
1	Fluorouracil (Carac)FDA LinkGeneric 07/2011
1	Peptides (Polypeptides)IBA 03/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2010
1	Transcription Factors (Transcription Factor)IBA 03/2009
1	AntigensIBA 10/2008
1	thiamine triphosphorate (TTP)IBA 10/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2008

Therapy/Procedure

19	Therapeutics 01/2022 - 11/2004
16	Drug Therapy (Chemotherapy) 12/2019 - 11/2004
2	Minimally Invasive Surgical Procedures 11/2021 - 08/2020
2	Microspheres (Microsphere) 12/2016 - 06/2014
1	Intravenous Administration 01/2021
1	Radiotherapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 08/2020
1	Aftercare (After-Treatment) 12/2019
1	Hepatectomy 03/2019
1	Therapeutic Embolization 01/2019
1	Neoadjuvant Therapy 07/2011
1	Glycemic Control 01/2009